(Q54409186)

English

Efficacy and safety of sustained (48 hour) intravenous infusions of milrinone in patients with severe congestive heart failure: a multicenter study.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/3549837

Efficacy and safety of sustained (48 hour) intravenous infusions of milrinone in patients with severe congestive heart failure: a multicenter study. (English)

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/3549837

0 references

1 reference

based on heuristic

inferred from title

congestive heart failure

1 reference

based on heuristic

inferred from title

author name string

J L Anderson

1

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/3549837

D S Baim

2

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/3549837

S A Fein

3

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/3549837

R A Goldstein

4

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/3549837

T H LeJemtel

5

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/3549837

M J Likoff

6

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/3549837

language of work or name

0 references

publication date

1 April 1987

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/3549837

Journal of the American College of Cardiology

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/3549837

9

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/3549837

4

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/3549837

711-722

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/3549837

The Natural History of Congestive Heart Failure: The Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The natural history of idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Vasodilator therapy of heart failure. Has the promissory note been paid?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Dobutamine: A New Synthetic Cardioactive Sympathetic Amine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Drugs five years later. Dobutamine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Tolerance to dobutamine after a 72 hour continuous infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Study of the normal and failing isolated human heart: Decreased response of failing heart to isoproterenol

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Decreased Lymphocyte Beta-Adrenergic-Receptor Density in Patients with Heart Failure and Tolerance to the Beta-Adrenergic Agonist Pirbuterol

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hemodynamic assessment of amrinone. A new inotropic agent

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Amrinone: a new non-glycosidic, non-adrenergic cardiotonic agent effective in the treatment of intractable myocardial failure in man

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hemodynamic comparison of intravenous amrinone and dobutamine in patients with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hemodynamic and clinical limitations of long-term inotropic therapy with amrinone in patients with severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral amrinone for the treatment of chronic congestive heart failure: results of a multicenter randomized double-blind and placebo-controlled withdrawal study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term oral administration of amrinone for congestive heart failure: lack of efficacy in a multicenter controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of a new bipyridine inotropic agent--milrinone--in patients with severe congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47203, in patients with severe congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term therapy with a new cardiotonic agent, WIN 47203: drug-dependent improvement in cardiac performance and progression of the underlying disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics and pharmacodynamics of milrinone in chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Improvement in indexes of diastolic performance in patients with congestive heart failure treated with milrinone

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Immediate effects of milrinone on metabolic and sympathetic responses to exercise in severe congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute dose range study of milrinone in congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Milrinone in congestive heart failure: acute and chronic hemodynamic and clinical evaluation.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of the direct vasodilator effect of milrinone with an isolated limb preparation in patients with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Separation of the direct myocardial and vasodilator actions of milrinone administered by an intracoronary infusion technique

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Milrinone in congestive heart failure: observations on ambulatory ventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Occurrence of ventricular arrhythmias in patients receiving acute and chronic infusions of milrinone

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Electrophysiologic effects of milrinone in patients with congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival of patients with severe congestive heart failure treated with oral milrinone

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Detrimental arrhythmogenic and sustained beneficial hemodynamic effects of oral salbutamol in patients with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0735-1097(87)80223-1

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/3549837

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/3549837

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54409186&oldid=1517773433"